跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈

Elsevier
通过我们出版

Sponsors & Exhibitors

Commercial opportunities

Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.

Download salespack

Reasons why being a sponsor is a brilliant marketing strategy

  • Highly targeted marketing – reach your community

  • Brand awareness & recognition – logo and advertisement placement

  • Access to knowledge – find out about new research being undertaken

  • Engage with your audience online

  • Media exposure - benefit from being promoted throughout Elsevier’s marketing process

  • Enhance credibility – highlight your company’s expertise to a captive audience

  • Generate new sales & form new partnerships – with registrants, vendors and speakers

  • Leveraged lead generation - the chance to be recommended to attendees’ connections

To discuss your requirements or to book sponsorship or exhibit space please contact:

Chloe Partridge Conference Sponsorship & Classified Advertising Sales Executive Tel: +44 (0) 1865 843 346 Email: [email protected]

Please do not email credit card information under any circumstances

Sponsors

Shionogi

Shionogi's policy is to "supply the best possible medicine to protect the health and wellbeing of the patients we serve." Our mission, based on this policy, as a research-driven pharmaceutical company, is to deliver pharmaceuticals that offer the greatest possible level of satisfaction to patients, their families, and healthcare providers and that improve quality of life (QOL) for patients and their families worldwide. To achieve this goal, we are constantly engaged in research, development, manufacturing, and marketing activities, with a primary focus on prescription medicines, including vaccines, as well as OTC drugs and diagnostics.

https://www.shionogi.com/global/en/

Shionogi

Silver sponsors

MINERVAX

MinervaX is committed to developing a vaccine to protect populations at risk of severe or life-threatening GBS infections, such as infants and older/at risk adults. Very promising clinical results have been obtained with vaccination in both pregnant (Ph2) and older adults (Ph1).

Website

MINERVAX

Takara Bio Inc.

Takara Bio Inc. provides cutting-edge CDMO services for gene and cell therapy, including mRNA production, viral vector manufacturing, cell processing and quality testing. In addition, we supply essential raw materials for therapeutics manufacturing, such as enzymes for mRNA synthesis, alongside a broad range of life science reagents and kits under the Takara, Clontech and Cellartis brands. Our mission is to contribute to the health of humankind through the development of revolutionary biotechnologies such as gene therapy.

For more information, visit takarabio.com.

Takara Bio Inc.

Exhibitors

EVORA

EVORA will contribute to strengthening the competitiveness of the European Research Area (ERA) by providing operational state-of-the-art facilities, supporting European industry in the field of communicable diseases and to providing recommendations for harmonised policies and regulations. Establishing an operational RI alliance that offers a range of tailored, integrated resources and preclinical research services for studying viral pathogens with epidemic or pandemic potential, will be the demonstration of EVORA’s success.

URL: https://evora-project.eu/

EVORA

Takara Bio Inc.

Takara Bio Inc. provides cutting-edge CDMO services for gene and cell therapy, including mRNA production, viral vector manufacturing, cell processing and quality testing. In addition, we supply essential raw materials for therapeutics manufacturing, such as enzymes for mRNA synthesis, alongside a broad range of life science reagents and kits under the Takara, Clontech and Cellartis brands. Our mission is to contribute to the health of humankind through the development of revolutionary biotechnologies such as gene therapy.

For more information, visit takarabio.com.

Takara Bio Inc.